Table 1 Severe and protracted diarrhoea in the patients with PIDs who responded to antibiotics.

From: A Nationwide Study of Severe and Protracted Diarrhoea in Patients with Primary Immunodeficiency Diseases

Gender

Tested age (months)

Genetic mutations

Colitis pathogen

Effective treatment [IgG level mg/dL at episode] (diarrhoea/treatment duration, days)**

TPN

Associated symptoms

(days)

Bronchiectasis

Sepsis

Other significant events (mortality, cause)

Predominantly antibody deficiencies

Btk1-1/M

40

Btk: Int 14 (−2)A > G; skip exon 14

undefined

IVIG [93], CTZ, AMK (15/16)

7

+

+

 

Btk1-2/M

14

Btk: Int 14 (−2)A > G; skip exon 14

Pseudomonas

IVIG [102], CTZ, AMK (14/15)

7

   

Btk2/M

9

Btk: c.1821C > T; p. Arg 641 Cys

Pseudomonas

IVIG [92], CTZ, AMK (14/15)

8

 

+

Recurrent cellulitis

Btk3/M

36

Btk: c. 1042 T > G; p. Phe304Val

Pseudomonas

IVIG [107], CTZ, AMK (14/15)

8

  

Recurrent sinopulmonary infections

Btk4/M

110

Btk: c.232 C > T; p. Glu78Stop

Salmonella

IVIG [205], CTX, CAR (14/16)

7

   

Btk5/M

26

Btk: c.1562 A > T; p. Asp 521 Val

Pseudomonas

IVIG [78], CTZ, AMK (17/19)

9

 

+

Polyarthritis, facial cellulitis

CVID1/M

273

Undefined*

undefined

IVIG [263], CTX, AMK (18/20)

10

+

 

Recurrent sinopulmonary infections

CVID2/M

127

Undefined*

undefined

IVIG [169], CTZ, AMK (15/17)

5

+

 

Recurrent sinopulmonary infections, failure to thrive

CVID3/M

129

Undefined*

undefined

IVIG [205], CTZ, AMK (14/16)

4

+

 

Recurrent sinopulmonary infections, Takayashi arteritis

CVID-4/F

92

Undefined*

Salmonella

IVIG [187], CTX (15/18)

5

  

Recurrent sinusitis, otitis media

Combined immunodeficiencies

SCID1-IL2RG/M

10

IL2RG: c. 220 T > G; p. Trp74Gly

E. coli

IVIG [104], CTX (14/17)

8

 

+

PJP, BCG-related infection, stem cell transplantation

SCID2-IL2RG/M

6

IL2RG: c. 676 G > T; p. Arg226Cys

Pseudomonas

IVIG [99], CTZ, AMK (14/16)

6

  

BCG-related infection, stem cell transplantation

SCID3-IL2RG/M

3

IL2RG: c. 865 C > T; Arg289Stop

Salmonella

IVIG, CTX (14/15)

5

  

Interstitial pneumonitis (respiratory failure)

SCID4-IL2RG/M

3

IL2RG: c.854 G > A, skip exon 6

Cytomegalovirus

IVIG [107], CTX, Gancyclovir (20/21)

12

 

+

Pneumonitis (respiratory failure)

SCID5/M

2

undefined

undefined

IVIG [245], CTZ, AMK (15/17)

7

+

 

Pneumonitis, pulmonary haemorrhage, (respiratory failure)

SCID6-RAG2/F

4

RAG1: Leu474Arg, Arg776Gln

undefined

IVIG [542], CTX, AMK (14/16)

7

  

Stem cell transplantation

HIGM1-CD40L/M

121

CD40L: Del 347 A

Cryptosporidium

IVIG [213], CTX, AMK (15/18), nitazoxanide (15/18)^

10

+

 

PJP, Recurrent sinopulmonary infections

HIGM2-CD40L/M

3

CD40L: c.526 T > A; p.Tyr 169 Asn

Salmonella

IVIG [87], CTX (17/19)

8

+

  

HIGM3-CD40L/M

5

CD40L: c.526 T > A; p.Tyr 169 Asn

E. coli Coxsackievirus B4

IVIG [112], CTX, AMK (14/15)

4

+

+

Cholecystitis, cholangitis, mortality (lymphoma)

Combined immunodeficiencies with associated or syndromic features

WAS1/M

3

WASP: Del promoter, exon 1 and 2

undefined

IVIG [421], CTX, AMK (14/17)

7

 

+

Bloody diarrhoea, mortality (Staphy. aureus sepsis)

WAS2/M

3

WASP: Del 243–250 nu

undefined

IVIG [354], CTX, AMK (14/16)

5

  

Bloody diarrhoea, severe atopic dermatitis, mortality (intracranial haemorrhage)

WAS3/M

2

WASP: c. 91 G > A, p. Glu31Lys

undefined

IVIG [743], CTX, AMK, MEP (18/20)

10

  

Bloody diarrhoea, stem cell transplantation

Congenital phagocyte number, function or both

CGD1-gp91/M

31

Gp91: Del 1693G

IBD-like

CTX, AMK, prednisolone (14/17)

5

+

 

Aspergillosis, pneumatocele, BCG-related infection

CGD2-gp91/M

14

Gp91: c.1028 C > A, p.Thr343Lys

Salmonella

CTX (14/15)

5

  

Staphy. aureus lymphadenitis, perianal ulcers, stem cell transplantation

CGD3-gp91/M

94

Gp91: c.1249 G > T, p. Gly412Val

Salmonella

CTX (14/16)

7

+

 

Aspergillosis, BCG-related infection, (respiratory failure)

CGD4-gp47/M

102

Gp47: del 75, 76GT (exon 2)

Pseudomonas

CTZ, AMK (14/17)

7

+

 

Aspergillosis, recurrent oral ulcers

  1. Abbreviations: CAR: carbapenems (100 mg/kg/day, divided q 6 hours); CTX: ceftriaxone (100 mg/kg/day); CTZ: ceftazidime (100 mg/kg/day); AMK: amikacin (15 mg/kg/day); IVIG: intravenous immunoglobulin (0.5–0.8 g/kg/dose); MEP: meropenem (20–30 mg/kg/day, divided q 12 hours); PJP, Pneumocystis jirovecii pneumonia; BCG, Bacillus Calmette-Guerin. “+” means “with” bronchiectasis or/and sepsis
  2. *The eight genes of inducible costimulator (ICOS), transmembrane activator and calcium modulator and cyclophilin ligand interactor (TACI), CD19, B-cell activating factor receptor (BAFFR), CD81, CD20, CD21, Cytotoxic T-lymphocyte–Associated antigen 4 (CTLA-4) and LPS-responsive beige-like anchor (LRBA) were analysed, but all were wild type.
  3. **ceftriaxone (100 mg/kg/day) was given for suspected Salmonella or Shigella colitis, and a combination of ceftazidime (100 mg/kg/day) and amikacin (15 mg/kg/day) for Pseudomonas colitis before the pathogen cultures were available.
  4. ^Nitazoxanide (200 mg/day bid) was discontinued when frequent diarrhoea had subsided and the stool culture became negative.